부산대학교 도서관

Maher T; Assassi S; Azuma A; Cottin V; Hoffmann-Vold AM; Kreuter M; Oldham JM; Richeldi L; Valenzuela C; Wijsenbeek MS; Clerisme-Beaty E; Coeck C; Gu H; Ritter I; Schlosser A; Stowasser S; Voss F; Weimann G; Zoz DF; Martinez FJ; FIBRONEER-ILD Trial Investigators; P C Elias; G P De Stefano; A Casey; V C Kohn; M J Fernandez; M A Bergna; G A Arce; L A Wehbe; H M Castro; M Otaola; I Glaspole; N Goh; J Wrobel; T Corte; J Wheatley; S Chapman; D Chambers; S Schembri; J Mackintosh; S Bowler; P Bremner; E Veitch; M Idzko; C Lambers; S Handzhiev; M Steinmaurer; A Valipour; M Rauter; H Flick; H Olschewski; M Studnicka; M-K Breyer; V Smith; W Wuyts; A Froidure; B Bondue; C Dahlqvist; J Guiot; H Slabbynck; A S Rubin; B G Baldi; M F Rabahi; S Jezler; G Zonzin; K M Storrer; E Fiss; E Mancuzo; W L L D Mattos; A L Francisco Pez; F E Arimura; C Ryerson; J D Rolf; G Cox; S Anees; G Dion; M Mallet; V Marcoux; H Manganas; E Millaire; D Assayag; D Marinescu; R S Silva Orellana; M R Salinas Fénero; Z Xu; J Chen; J Cao; H Peng; Q Luo; J Xu; M Cao; F Li; H Zhu; T Bian; H Dai; F Wen; A Cui; H Zhang; W Ma; W Huang; L Wang; X Zhang; Y Meng; K Hu; L Gao; J Ni; X Xu; X Wang; Q Hong; S Yang; G Shi; J Gao; B Chen; T Zhao; H Wu; W Li; Y Fu; Q Zhang; E Chen; J Huang; L Rong; D Zhu; J Ye; M Gomercic Palcic; A Hecimovic; D Ljubicic; M Sterclova; E Bendstrup; S B Shaker; I Titlestad; M Jaanus; M Myllärniemi; M Kilpeläinen; I Strander; R Kaarteenaho; M Salaun; G Prévot; E Bergot; S Jouneau; S Hirschi; L Stervinou-Wemeau; F Lebargy; B Crestani; V Cottin; M Reynaud-Gaubert; F Gagnadoux; S Quetant; J Mankikian; S Marchand-Adam; H Nunes; S Dirou; A Chabrol; S Leroy; P Bonniaud; E Blanchard; D Israel-Biet; A Bourdin; F Couturaud; E Sherozia; D Tchkonia; D Koschel; A-M Kirsten; J Kirschner; S Walterspacher; H-J Kabitz; J Behr; F Herth; M Kreuter; P Hammerl; F Bonella; J Ficker; W Spengler; T Oqueka; L Hagmeyer; M Westhoff; T Fühner; C Warnke; S Gläser; D Skowasch; C Neurohr; S Gregor; R Wiewrodt; A Prasse; K Antoniou; P Sfikakis; T Dimitroulas; A Tzouvelekis; K Tatsis; K Kostikas; V Muller; R Gajdocsi; A Sarkozi; M Kawedia; S Krishnamurthy; S Rajan; Z Udwadia; K O'Reilly; G Izbicki; B Fox; Y Raviv; Y Adir; A Bar-Shai; L Richeldi; E Balestro; E Bargagli; M Bonifazi; S Cerri; S Harari; D Lacedonia; F Luppi; M Mondoni; C Ravaglia; P Rogliani; S Tomassetti; C Vancheri; M Bocchino; P Ceruti; Marco Confalonieri; K Kataoka; M Bando; Y Miyazaki; K Tomii; Y Kaneko; K Murakami; S Izumi; K Tobino; H Tomioka; T Kawamura; N Sakamoto; H Ishii; T Takeuchi; Y Fujieda; M Kato; H Kitamura; M Okamoto; T Suda; T Arai; Y Inoue; O Nishiyama; K Imaizumi; S Nakayamada; T Handa; K Ichikado; K Kuronuma; S Sato; K Kishi; Y Waseda; K Sugino; H Akamatsu; D Fujimoto; I Okamoto; H Matsushima; N Ishikawa; H Dobashi; S Abe; Y Tanino; Y Zaizen; M Kuwana; M Tamaoka; N A Muhammad; S S Sirol Aflah; L Pereirasamy; S S Kho; U Chavarria-Martinez; P Basaldua Zaragoza; J Martinez Diaz; R M Barriga Acevedo; A Arreola Morales; E A Reyes Garcia; A Ramirez Venegas; A A Colli Dominguez; R L Mostard; M Wijsenbeek-Lourens; M Veltkamp; M Geelhoed; C Chang; M Wilsher; C O'Dochartaigh; S Poole; T L Eagan; R Gagama; M Durheim; A Barczyk; A Sieminska; W Tomkowski; K Gorska; B Mackiewicz; A Morais; S Fernandes; S Neves; A Borba; I Neves; R Rolo; M-P Chung; H-Y Yoon; J S Park; J-M Park; Y H Kim; M S Park; Y-S Choi; J W Song; R Abdulqawi; S Alyami; M Khalafallah; M Ilic; S Mojsilovic; M Stjepanovic; T Pejcic; S Y Low; G T Chai; K Osolnik; H J van Rensburg; I Abdullah; A Ambaram; M Arias; M Molina-Molina; J Sellares; M Aburto; M V Leal Arranz; B Salinas; J Suárez Antelo; C Valenzuela; J M Echave Sustaeta; J Rigual; R García Sevila; E Balcells; R Pérez Rojo; S Eizaguirre; J Cifrián; Z Palacios; J De Miguel Díaz; J A Rodríguez Portal; J L Velasco; B López Muñiz; J A Ros; A D Romero Ortiz; O Emilsson; E Ekbom; K Hostettler Haack; S Guler; P-K Fu; C-H Lin; K-T Huang; C-C Sheu; T-H Huang; M-H Chen; J-L Lan; S Disayabutr; P Ratanawatkul; T Petnak; A Limsukon; K Bangpattanasiri; A Navasakulpong; F Coskun; A Cilli; N Ocal; O O Kumbasar; G Okumus; N Y Demirci; P L Molyneaux; N Hirani; H Adamali; P Beirne; M Gibbons; D Parekh; D Dosanjh; A West; R Hoyles; S Fletcher; O Dempsey; C Hayton; P Rivera-Ortega; T Gatheral; M Kelly; S K Danoff; M B Scholand; M Hamblin; S Bellam; A Milstone; N Warshoff; C Harden; D Patel; J Hewlett; L Lancaster; A Hajari Case; H J Kim; D Phillips; J Lasky; P LaCamera; T M Maher; D Zhang; T Kulkarni; F Averill; T Kaelin; C Braun; T Moua; D Hotchkin; T Russell; G Hunninghake; S Weigt; F Alabi; Y Mageto; S Mathai; R Fowler; L Morrison; T Zaman; S Chaudhary; S Halliday; J Roman; M Kreider; R Kaner; N Gupta; A Desai; D Hershberger; R Dixon; C Mello; T Albertson; A Nambiar; B Mina; O Shlobin; S Kable; B Shea; F Kassamali Madhani-Lovely; D Antin-Ozerkis; A Aranda-Rodriguez; S Veeraraghavan; S Levy; B Flashner; J Zibrak; B Disilvio; T Cheema; E Blackstock; P Crossno; J Swigris; J Solomon; M Kokoszynska; A Gerbino; N Bhatt; J Sheth; K Flaherty; G Nair; G Criner; L Tolle.

New England Journal of Medicine. 392:2203-2214

Michael Kreuter; Elizabeth A. Belloli; Elisabeth Bendstrup; Stefania Cerri; Kevin R. Flaherty; Shane Shapera; Jin Woo Song; Heiko Mueller; Klaus B. Rohr; Yasuhiro Kondoh; on behalf of the INBUILD trial investigators; S. Quadrelli; M. Otaola; M.A. Bergna; P. Elias; G. Arce; A. Cazaux; J. Guiot; B. Bondue; C. Dahlqvist; L. Homik; S. Shapera; A. Cantin; M. Kolb; M. Salinas Fénero; R. Maturana Rozas; A. Silva Orellana; Z. Xu; Q. Luo; J. Kang; H. Cai; S. Marchand-Adam; E. Bergot; A. Gamez-Dubuis; F. Riviere; R. Kessler; H. Nunes; C. Marquette; L. Wemeau; S. Jouneau; F. Lebargy; B. Crestani; V. Cottin; M. Reynaud-Gaubert; S. Blaas; F. Bonella; W. Randerath; J. Hetzel; D. Koschel; M. Kreuter; A. Prasse; D. Skowasch; S. Stieglitz; R. Refini; S. Cerri; A. Pesci; S. Tomassetti; C. Vancheri; F. Varone; N. Sakamoto; S. Abe; H. Hayashi; T. Saito; T. Suda; H. Kitamura; M. Okamoto; Y. Kondoh; S. Makino; T. Takeuchi; Y. Yamada; C. Kono; Y. Inoue; H. Sugiura; K. Kishi; H. Takaya; H. Yamauchi; K. Ichikado; K. Tomii; H. Takahashi; S. Izumi; T. Kawamura; Y. Nishioka; Y. Miyazaki; J.W. Song; J.S. Park; Y. Kim; E. Jassem; J. Kus; W. Piotrowski; A. Barczyk; D. Ziora; E. Bazdyrev; S. Moiseev; S. Avdeev; M. Ilkovich; V. Yakusevich; C. Valenzuela; O. Acosta; M. Martínez; L. Gómez; M. Molina-Molina; D.M. Castillo Villegas; M. Aburto; J.A. Rodríguez Portal; A. Villar; A. León Jiménez; J. Sauleda; M. Arias; P. Beirne; H. Stone; B. Hope-Gill; N. Hirani; N. Chaudhuri; A. Gifford; L. Jones; L. Morrison; D. Antin-Ozerkis; N. Bhatt; T. Kulkarni; T. Moua; N. Ettinger; L. Pitts; S. Veeraraghavan; M. Padilla; E.R. Fernández Pérez; G. Giessel; M. Strek; S. Danoff; J. Burk; M. Rossman; N. Patel; E. Belloli; D. Hotchkin; S. Weigt; M.B. Scholand; R. Kaner; B. Sigal; Z. Safdar; L. Tolle; R. Martinez; M. Glassberg; R. Hallowell; J. Golden; M. Schwartz; E. Britt; L. Morrow; Y. Mageto; K. Buch; S. Chaaban; H. Poonyagariyagorn; D. Dilling; O. Shlobin; K. Thavarajah; A. Nambiar; I. Rosas; R. Bascom; J. Oldham; S. Schmidt; J. Dematte D'Amico; J. Falk; C. Glazer; G. Criner

ERJ Open Research, Vol 10, Iss 6 (2024)

Wells, A. U.; Flaherty, K. R.; Brown, K. K.; Inoue, Y.; Devaraj, A.; Richeldi, L.; Moua, T.; Crestani, B.; Wuyts, W. A.; Stowasser, S.; Quaresma, M.; Goeldner, R.-G.; Schlenker-Herceg, R.; Kolb, M.; Abe, S.; Aburto, M.; Acosta, O.; Andrews, C.; Antin-Ozerkis, D.; Arce, G.; Arias, M.; Avdeev, S.; Barczyk, A.; Bascom, R.; Bazdyrev, E.; Beirne, P.; Belloli, E.; Bergna, M. A.; Bergot, E.; Bhatt, N.; Blaas, S.; Bondue, B.; Bonella, F.; Britt, E.; Buch, K.; Burk, J.; Cai, H.; Cantin, A.; Castillo Villegas, D. M.; Cazaux, A.; Cerri, S.; Chaaban, S.; Chaudhuri, N.; Cottin, V.; Criner, G.; Dahlqvist, Carl-Henrik; Danoff, S.; Dematte D'Amico, J.; Dilling, D.; Elias, P.; Ettinger, N.; Falk, J.; Fernández Pérez, E. R.; Gamez-Dubuis, A.; Giessel, G.; Gifford, A.; Glassberg, M.; Glazer, C.; Golden, J.; Gómez Carrera, L.; Guiot, Julien; Hallowell, R.; Hayashi, H.; Hetzel, J.; Hirani, N.; Homik, L.; Hope-Gill, B.; Hotchkin, D.; Ichikado, K.; Ilkovich, M.; Izumi, S.; Jassem, E.; Jones, L.; Jouneau, S.; Kaner, R.; Kang, J.; Kawamura, T.; Kessler, R.; Kim, Y.; Kishi, K.; Kitamura, H.; Kondoh, Y.; Kono, C.; Koschel, D.; Kreuter, M.; Kulkarni, T.; Kus, J.; Lebargy, F.; León Jiménez, A.; Luo, Q.; Mageto, Y.; Maher, T. M.; Makino, S.; Marchand-Adam, S.; Marquette, C.; Martinez, R.; Martínez, M.; Maturana Rozas, R.; Miyazaki, Y.; Moiseev, S.; Molina-Molina, M.; Morrison, L.; Morrow, L.; Nambiar, A.; Nishioka, Y.; Nunes, H.; Okamoto, M.; Oldham, J.; Otaola, M.; Padilla, M.; Park, J. S.; Patel, N.; Pesci, A.; Piotrowski, W.; Pitts, L.; Poonyagariyagorn, H.; Prasse, A.; Quadrelli, S.; Randerath, W.; Refini, R.; Reynaud-Gaubert, M.; Riviere, F.; Rodríguez Portal, J. A.; Rosas, I.; Rossman, M.; Safdar, Z.; Saito, T.; Sakamoto, N.; Salinas Fénero, M.; Sauleda, J.; Schmidt, S.; Scholand, M. B.; Schwartz, M.; Shapera, S.; Shlobin, O.; Sigal, B.; Silva Orellana, A.; Skowasch, D.; Song, J. W.; Stieglitz, S.; Stone, H.; Strek, M.; Suda, T.; Sugiura, H.; Takahashi, H.; Takaya, H.; Takeuchi, T.; Thavarajah, K.; Tolle, L.; Tomassetti, S.; Tomii, K.; Valenzuela, C.; Vancheri, C.; Varone, F.; Veeraraghavan, S.; Villar, A.; Weigt, S.; Wemeau, L.; Wuyts, W.; Xu, Z.; Yakusevich, V.; Yamada, Y.; Yamauchi, H.; Ziora, D.

The Lancet. Respiratory medicine, 8 (5
Wells, AU, Flaherty, KR, Brown, KK, Inoue, Y, Devaraj, A, Richeldi, L, Moua, T, Crestani, B, Wuyts, WA, Stowasser, S, Quaresma, M, Goeldner, RG & investigators, INBUILD T 2020, ' Nintedanib in patients with progressive fibrosing interstitial lung diseases-subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial. ', The Lancet. Respiratory medicine . https://doi.org/10.1016/s2213-2600(20)30036-9

Flaherty K. R.; Wells A. U.; Cottin V.; Devaraj A.; Walsh S. L. F.; Inoue Y.; Richeldi L.; Kolb M.; Tetzlaff K.; Stowasser S.; Coeck C.; Clerisme-Beaty E.; Rosenstock B.; Quaresma M.; Haeufel T.; Goeldner R. -G.; Schlenker-Herceg R.; Brown K. K. INBUILD Investigators: S Quadrelli; M Otaola; M A Bergna; P Elias; G Arce; A Cazaux; W Wuyts; J Guiot; B Bondue; C Dahlqvist; L Homik; S Shapera; A Cantin; M Kolb; M Salinas Fénero; R Maturana Rozas; A Silva Orellana; Z Xu; Q Luo; J Kang; H Cai; S Marchand-Adam; E Bergot; A Gamez-Dubuis; F Riviere; R Kessler; H Nunes; C Marquette; L Wemeau; S Jouneau; F Lebargy; B Crestani; V Cottin; M Reynaud-Gaubert; S Blaas; F Bonella; W Randerath; J Hetzel; D Koschel; M Kreuter; A Prasse; D Skowasch; S Stieglitz; R Refini; S Cerri; A Pesci; S Tomassetti; C Vancheri; F Varone; N Sakamoto; S Abe; H Hayashi 3rd; T Saito; T Suda; H Kitamura; M Okamoto; Y Kondoh; S Makino; T Takeuchi; Y Yamada; C Kono; Y Inoue; H Sugiura; K Kishi; H Takaya; H Yamauchi; K Ichikado; K Tomii; H Takahashi; S Izumi; T Kawamura; Y Nishioka; Y Miyazaki; J W Song; J S Park; Y Kim; E Jassem; J Kus; W Piotrowski; A Barczyk; D Ziora; E Bazdyrev; S Moiseev; S Avdeev; M Ilkovich; V Yakusevich; C Valenzuela; O Acosta; M Martínez; L Gómez Carrera; M Molina-Molina; D M Castillo Villegas; M Aburto; J A Rodríguez Portal; A Villar; A León Jiménez; J Sauleda; M Arias; T M Maher; P Beirne; H Stone; B Hope-Gill; N Hirani; N Chaudhuri; C Andrews; A Gifford; L Jones; L Morrison; D Antin-Ozerkis; N Bhatt; T Kulkarni; T Moua; N Ettinger; L Pitts; S Veeraraghavan; M Padilla; E R Fernández Pérez; G Giessel; M Strek; S Danoff; J Burk; M Rossman; N Patel; E Belloli; D Hotchkin; S Weigt; M B Scholand; R Kaner; B Sigal; Z Safdar; L Tolle; R Martinez; M Glassberg; R Hallowell; J Golden; M Schwartz; E Britt; L Morrow; Y Mageto; K Buch; S Chaaban; H Poonyagariyagorn; D Dilling; O Shlobin; K Thavarajah; A Nambiar; I Rosas; R Bascom; J Oldham; S Schmidt; J Dematte D'Amico; J Falk; C Glazer; G Criner

The New England journal of medicine, Vol. 381, no. 18, p. 1718-1727 (2019)
The New England journal of medicine, 381 (18
Flaherty, KR, Cottin, V, Devaraj, A, Walsh, SLF, Inoue, Y, Richeldi, L, Kolb, M, Tetzlaff, K, Stowasser, S, Coeck, C, Clerisme-Beaty, E, Rosenstock, B & Investigators, INBUILD T 2019, ' Nintedanib in Progressive Fibrosing Interstitial Lung Diseases. ', The New England Journal of Medicine . https://doi.org/10.1056/nejmoa1908681

Richeldi L; Unità Operativa Complessa di Pneumologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome.; Azuma A; Clinical Research Center, Mihara General Hospital, Saitama, Japan.; Nippon Medical School, Tokyo.; Cottin V; National Reference Center for Rare Pulmonary Diseases, Louis Pradel Hospital, Hospices Civils de Lyon, Claude Bernard University Lyon 1, Unité Mixte de Recherche 754, European Reference Network for Rare Respiratory Diseases, Lyon, France.; Kreuter M; Center for Pulmonary Medicine, Department of Pneumology, Mainz University Medical Center, Mainz, Germany.; Pulmonary, Critical Care, and Sleep Medicine, Marienhaus Clinic Mainz, Mainz, Germany.; Maher TM; Department of Pulmonary, Critical Care, and Sleep Medicine, Keck School of Medicine, University of Southern California, Los Angeles.; Section of Inflammation, Repair, and Development, National Heart and Lung Institute, Imperial College London, London.; Martinez FJ; University of Massachusetts (UMass) Chan Medical School-UMass Memorial Health System, Worcester.; Oldham JM; Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor.; Valenzuela C; Pulmonology Department, Hospital Universitario de la Princesa, Universidad Autónoma de Madrid, Madrid.; Clerisme-Beaty E; Therapy Area Inflammation Medicine, Boehringer Ingelheim International, Ingelheim am Rhein, Germany.; Gordat M; Clinical Development and Operation Department, Boehringer Ingelheim, Reims, France.; Wachtlin D; Department of Biostatistics and Data Sciences, Boehringer Ingelheim Pharma, Ingelheim am Rhein, Germany.; Liu Y; Department of Biostatistics and Data Sciences, Boehringer Ingelheim Pharmaceuticals, Ridgefield, CT.; Schlecker C; Global Patient Safety and Pharmacovigilance, Boehringer Ingelheim International, Ingelheim am Rhein, Germany.; Stowasser S; Therapy Area Inflammation Medicine, Boehringer Ingelheim International, Ingelheim am Rhein, Germany.; Zoz DF; Global Clinical Development and Medical Affairs, Boehringer Ingelheim Pharmaceuticals, Ridgefield, CT.; Wijsenbeek MS; Center of Expertise for Interstitial Lung Diseases, Department of Respiratory Medicine, Erasmus MC, University Medical Center, Rotterdam, the Netherlands.

Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1533-4406 (Electronic) Linking ISSN: 00284793 NLM ISO Abbreviation: N Engl J Med Subsets: MEDLINE

Richeldi L; From Unità Operativa Complessa di Pneumologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome (L.R.); Nippon Medical School, Tokyo (A.A.); Hôpital Louis Pradel, Centre National de Référence des Maladies Pulmonaires Rares, Hospices Civils de Lyon, Unité Mixte de Recherche 754 Institut National de la Recherche Agronomique and Université Claude Bernard Lyon 1, ERN-LUNG (European Reference Network on Rare Respiratory Diseases), RespiFil, OrphaLung, Lyon, France (V.C.); Translational Medicine and Clinical Pharmacology, Boehringer Ingelheim International, Biberach (C.H.), and TA Inflammation Medicine (S.S.), Boehringer Ingelheim Pharma (F.V.), Ingelheim am Rhein - both in Germany; the Interstitial Lung Disease Unit, Department of Pulmonology, Hospital Universitario de la Princesa, University Autonoma de Madrid, Madrid (C.V.); the Department of Respiratory Medicine, Erasmus Medical Center, Rotterdam, the Netherlands (M.S.W.); Boehringer Ingelheim Pharmaceuticals, Ridgefield, CT (D.F.Z.); Keck School of Medicine, University of Southern California, Los Angeles (T.M.M.); and the National Heart and Lung Institute, Imperial College London, London (T.M.M.).; Azuma A; From Unità Operativa Complessa di Pneumologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome (L.R.); Nippon Medical School, Tokyo (A.A.); Hôpital Louis Pradel, Centre National de Référence des Maladies Pulmonaires Rares, Hospices Civils de Lyon, Unité Mixte de Recherche 754 Institut National de la Recherche Agronomique and Université Claude Bernard Lyon 1, ERN-LUNG (European Reference Network on Rare Respiratory Diseases), RespiFil, OrphaLung, Lyon, France (V.C.); Translational Medicine and Clinical Pharmacology, Boehringer Ingelheim International, Biberach (C.H.), and TA Inflammation Medicine (S.S.), Boehringer Ingelheim Pharma (F.V.), Ingelheim am Rhein - both in Germany; the Interstitial Lung Disease Unit, Department of Pulmonology, Hospital Universitario de la Princesa, University Autonoma de Madrid, Madrid (C.V.); the Department of Respiratory Medicine, Erasmus Medical Center, Rotterdam, the Netherlands (M.S.W.); Boehringer Ingelheim Pharmaceuticals, Ridgefield, CT (D.F.Z.); Keck School of Medicine, University of Southern California, Los Angeles (T.M.M.); and the National Heart and Lung Institute, Imperial College London, London (T.M.M.).; Cottin V; From Unità Operativa Complessa di Pneumologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome (L.R.); Nippon Medical School, Tokyo (A.A.); Hôpital Louis Pradel, Centre National de Référence des Maladies Pulmonaires Rares, Hospices Civils de Lyon, Unité Mixte de Recherche 754 Institut National de la Recherche Agronomique and Université Claude Bernard Lyon 1, ERN-LUNG (European Reference Network on Rare Respiratory Diseases), RespiFil, OrphaLung, Lyon, France (V.C.); Translational Medicine and Clinical Pharmacology, Boehringer Ingelheim International, Biberach (C.H.), and TA Inflammation Medicine (S.S.), Boehringer Ingelheim Pharma (F.V.), Ingelheim am Rhein - both in Germany; the Interstitial Lung Disease Unit, Department of Pulmonology, Hospital Universitario de la Princesa, University Autonoma de Madrid, Madrid (C.V.); the Department of Respiratory Medicine, Erasmus Medical Center, Rotterdam, the Netherlands (M.S.W.); Boehringer Ingelheim Pharmaceuticals, Ridgefield, CT (D.F.Z.); Keck School of Medicine, University of Southern California, Los Angeles (T.M.M.); and the National Heart and Lung Institute, Imperial College London, London (T.M.M.).; Hesslinger C; From Unità Operativa Complessa di Pneumologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome (L.R.); Nippon Medical School, Tokyo (A.A.); Hôpital Louis Pradel, Centre National de Référence des Maladies Pulmonaires Rares, Hospices Civils de Lyon, Unité Mixte de Recherche 754 Institut National de la Recherche Agronomique and Université Claude Bernard Lyon 1, ERN-LUNG (European Reference Network on Rare Respiratory Diseases), RespiFil, OrphaLung, Lyon, France (V.C.); Translational Medicine and Clinical Pharmacology, Boehringer Ingelheim International, Biberach (C.H.), and TA Inflammation Medicine (S.S.), Boehringer Ingelheim Pharma (F.V.), Ingelheim am Rhein - both in Germany; the Interstitial Lung Disease Unit, Department of Pulmonology, Hospital Universitario de la Princesa, University Autonoma de Madrid, Madrid (C.V.); the Department of Respiratory Medicine, Erasmus Medical Center, Rotterdam, the Netherlands (M.S.W.); Boehringer Ingelheim Pharmaceuticals, Ridgefield, CT (D.F.Z.); Keck School of Medicine, University of Southern California, Los Angeles (T.M.M.); and the National Heart and Lung Institute, Imperial College London, London (T.M.M.).; Stowasser S; From Unità Operativa Complessa di Pneumologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome (L.R.); Nippon Medical School, Tokyo (A.A.); Hôpital Louis Pradel, Centre National de Référence des Maladies Pulmonaires Rares, Hospices Civils de Lyon, Unité Mixte de Recherche 754 Institut National de la Recherche Agronomique and Université Claude Bernard Lyon 1, ERN-LUNG (European Reference Network on Rare Respiratory Diseases), RespiFil, OrphaLung, Lyon, France (V.C.); Translational Medicine and Clinical Pharmacology, Boehringer Ingelheim International, Biberach (C.H.), and TA Inflammation Medicine (S.S.), Boehringer Ingelheim Pharma (F.V.), Ingelheim am Rhein - both in Germany; the Interstitial Lung Disease Unit, Department of Pulmonology, Hospital Universitario de la Princesa, University Autonoma de Madrid, Madrid (C.V.); the Department of Respiratory Medicine, Erasmus Medical Center, Rotterdam, the Netherlands (M.S.W.); Boehringer Ingelheim Pharmaceuticals, Ridgefield, CT (D.F.Z.); Keck School of Medicine, University of Southern California, Los Angeles (T.M.M.); and the National Heart and Lung Institute, Imperial College London, London (T.M.M.).; Valenzuela C; From Unità Operativa Complessa di Pneumologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome (L.R.); Nippon Medical School, Tokyo (A.A.); Hôpital Louis Pradel, Centre National de Référence des Maladies Pulmonaires Rares, Hospices Civils de Lyon, Unité Mixte de Recherche 754 Institut National de la Recherche Agronomique and Université Claude Bernard Lyon 1, ERN-LUNG (European Reference Network on Rare Respiratory Diseases), RespiFil, OrphaLung, Lyon, France (V.C.); Translational Medicine and Clinical Pharmacology, Boehringer Ingelheim International, Biberach (C.H.), and TA Inflammation Medicine (S.S.), Boehringer Ingelheim Pharma (F.V.), Ingelheim am Rhein - both in Germany; the Interstitial Lung Disease Unit, Department of Pulmonology, Hospital Universitario de la Princesa, University Autonoma de Madrid, Madrid (C.V.); the Department of Respiratory Medicine, Erasmus Medical Center, Rotterdam, the Netherlands (M.S.W.); Boehringer Ingelheim Pharmaceuticals, Ridgefield, CT (D.F.Z.); Keck School of Medicine, University of Southern California, Los Angeles (T.M.M.); and the National Heart and Lung Institute, Imperial College London, London (T.M.M.).; Wijsenbeek MS; From Unità Operativa Complessa di Pneumologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome (L.R.); Nippon Medical School, Tokyo (A.A.); Hôpital Louis Pradel, Centre National de Référence des Maladies Pulmonaires Rares, Hospices Civils de Lyon, Unité Mixte de Recherche 754 Institut National de la Recherche Agronomique and Université Claude Bernard Lyon 1, ERN-LUNG (European Reference Network on Rare Respiratory Diseases), RespiFil, OrphaLung, Lyon, France (V.C.); Translational Medicine and Clinical Pharmacology, Boehringer Ingelheim International, Biberach (C.H.), and TA Inflammation Medicine (S.S.), Boehringer Ingelheim Pharma (F.V.), Ingelheim am Rhein - both in Germany; the Interstitial Lung Disease Unit, Department of Pulmonology, Hospital Universitario de la Princesa, University Autonoma de Madrid, Madrid (C.V.); the Department of Respiratory Medicine, Erasmus Medical Center, Rotterdam, the Netherlands (M.S.W.); Boehringer Ingelheim Pharmaceuticals, Ridgefield, CT (D.F.Z.); Keck School of Medicine, University of Southern California, Los Angeles (T.M.M.); and the National Heart and Lung Institute, Imperial College London, London (T.M.M.).; Zoz DF; From Unità Operativa Complessa di Pneumologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome (L.R.); Nippon Medical School, Tokyo (A.A.); Hôpital Louis Pradel, Centre National de Référence des Maladies Pulmonaires Rares, Hospices Civils de Lyon, Unité Mixte de Recherche 754 Institut National de la Recherche Agronomique and Université Claude Bernard Lyon 1, ERN-LUNG (European Reference Network on Rare Respiratory Diseases), RespiFil, OrphaLung, Lyon, France (V.C.); Translational Medicine and Clinical Pharmacology, Boehringer Ingelheim International, Biberach (C.H.), and TA Inflammation Medicine (S.S.), Boehringer Ingelheim Pharma (F.V.), Ingelheim am Rhein - both in Germany; the Interstitial Lung Disease Unit, Department of Pulmonology, Hospital Universitario de la Princesa, University Autonoma de Madrid, Madrid (C.V.); the Department of Respiratory Medicine, Erasmus Medical Center, Rotterdam, the Netherlands (M.S.W.); Boehringer Ingelheim Pharmaceuticals, Ridgefield, CT (D.F.Z.); Keck School of Medicine, University of Southern California, Los Angeles (T.M.M.); and the National Heart and Lung Institute, Imperial College London, London (T.M.M.).; Voss F; From Unità Operativa Complessa di Pneumologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome (L.R.); Nippon Medical School, Tokyo (A.A.); Hôpital Louis Pradel, Centre National de Référence des Maladies Pulmonaires Rares, Hospices Civils de Lyon, Unité Mixte de Recherche 754 Institut National de la Recherche Agronomique and Université Claude Bernard Lyon 1, ERN-LUNG (European Reference Network on Rare Respiratory Diseases), RespiFil, OrphaLung, Lyon, France (V.C.); Translational Medicine and Clinical Pharmacology, Boehringer Ingelheim International, Biberach (C.H.), and TA Inflammation Medicine (S.S.), Boehringer Ingelheim Pharma (F.V.), Ingelheim am Rhein - both in Germany; the Interstitial Lung Disease Unit, Department of Pulmonology, Hospital Universitario de la Princesa, University Autonoma de Madrid, Madrid (C.V.); the Department of Respiratory Medicine, Erasmus Medical Center, Rotterdam, the Netherlands (M.S.W.); Boehringer Ingelheim Pharmaceuticals, Ridgefield, CT (D.F.Z.); Keck School of Medicine, University of Southern California, Los Angeles (T.M.M.); and the National Heart and Lung Institute, Imperial College London, London (T.M.M.).; Maher TM; From Unità Operativa Complessa di Pneumologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome (L.R.); Nippon Medical School, Tokyo (A.A.); Hôpital Louis Pradel, Centre National de Référence des Maladies Pulmonaires Rares, Hospices Civils de Lyon, Unité Mixte de Recherche 754 Institut National de la Recherche Agronomique and Université Claude Bernard Lyon 1, ERN-LUNG (European Reference Network on Rare Respiratory Diseases), RespiFil, OrphaLung, Lyon, France (V.C.); Translational Medicine and Clinical Pharmacology, Boehringer Ingelheim International, Biberach (C.H.), and TA Inflammation Medicine (S.S.), Boehringer Ingelheim Pharma (F.V.), Ingelheim am Rhein - both in Germany; the Interstitial Lung Disease Unit, Department of Pulmonology, Hospital Universitario de la Princesa, University Autonoma de Madrid, Madrid (C.V.); the Department of Respiratory Medicine, Erasmus Medical Center, Rotterdam, the Netherlands (M.S.W.); Boehringer Ingelheim Pharmaceuticals, Ridgefield, CT (D.F.Z.); Keck School of Medicine, University of Southern California, Los Angeles (T.M.M.); and the National Heart and Lung Institute, Imperial College London, London (T.M.M.).

Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1533-4406 (Electronic) Linking ISSN: 00284793 NLM ISO Abbreviation: N Engl J Med Subsets: MEDLINE